You are here: Industry Insights > HIV

News List

Why are children waiting so long for new meds? expresspharma
June 10, 2020
COVID-19 and drug resistance are threatening to derail the progress made against the HIV, malaria and TB epidemics, and this may have a negative impact on child healthcare: Access to Medicine Foundation.
Just - Evotec Biologics, ABL Enter Clinical Supply Pact contractpharma
June 10, 2020
Just - Evotec Biologics to design a manufacturing process for the production of Phase I cGMP clinical supply of a broadly neutralizing antibody against HIV.
Codiak BioSciences collaborates with Ragon Institute to evaluate exoVACC vaccine platform in SARS-Co pharmaceutical-business-review
June 04, 2020
Codiak BioSciences announced that it has entered into two strategic collaborations with the Ragon Institute of MGH, MIT and Harvard to investigate ...
FDA Grants Accelerated Approval to Pomalidomide for Kaposi Sarcoma americanpharmaceuticalreview
May 21, 2020
The Food and Drug Administration (FDA) expanded the indication of pomalidomide (POMALYST, Celgene Corporation).
ViiV HIV prevention trial stopped early on efficacy pharmatimes
May 19, 2020
ViiV Healthcare's trial assessing an investigational, long-acting injection for HIV prevention has been stopped early due to high levels of efficacy.
GSK’s long-acting injection beats Truvada in HIV prevention trial expresspharma
May 19, 2020
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection.
Oral polio vaccine can be effective against coronavirus: HIV co-discoverer expresspharma
April 27, 2020
The vaccine has been documented to provide protection against a number of viral and bacterial infections other than poliomyelitis, including flu, said Dr Robert Gallo.
Hep C cases down around 70% in HIV positive men in London and Brighton pharmatimes
March 26, 2020
An analysis of five clinics in London and Brighton has revealed that new cases of hepatitis C amongst HIV positive men in the areas have fallen by nearly 70% in recent years.
ViiV Healthcare secures Canadian approval for HIV drug regimen CABENUVA pharmaceutical-business-review
March 25, 2020
ViiV Healthcare has secured approval for CABENUVA (cabotegravir and rilpivirine extended-release injectable suspensions) from Health Canada for the treatment of HIV-1 infection in adults.
ViiV Healthcare, Janssen get Canadian approval for Cabenuva pharmaceutical-technology
March 24, 2020
ViiV Healthcare and Janssen Pharmaceutical have announced the Health Canada approval of Cabenuva as a once-monthly, long-acting therapy for adults with HIV-1 infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page